Vicapsys Life Sciences, Inc. (OTCMKTS:VICP – Get Free Report) shares dropped 36.1% on Wednesday . The company traded as low as $0.62 and last traded at $0.62. Approximately 107 shares changed hands during trading, a decline of 40% from the average daily volume of 179 shares. The stock had previously closed at $0.97.
Vicapsys Life Sciences Trading Down 36.1 %
The stock has a fifty day moving average price of $1.78 and a two-hundred day moving average price of $2.21.
About Vicapsys Life Sciences
Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers.
See Also
- Five stocks we like better than Vicapsys Life Sciences
- How to Invest in Blue Chip Stocks
- United Airlines Soars on Earnings Beat
- What is a Dividend King?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Most Volatile Stocks, What Investors Need to Know
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Vicapsys Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicapsys Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
